Granulocytosis refers to an abnormal increase in the number of granulocytes in the blood. These cells, primarily neutrophils, eosinophils, and basophils, are part of the white blood cells and play a direct role in defending against infections. When their concentration exceeds normal values, the phenomenon almost always indicates a response from the body to an aggression or an underlying dysfunction.
Granulocytes and blood count: what the values indicate
Granulocytes get their name from the visible granules in their cytoplasm under a microscope. Among them, neutrophils represent the most abundant and closely monitored fraction in clinical practice.
During a complete blood count (CBC), the doctor evaluates the proportion of each type of white blood cell. An isolated elevation of neutrophils points towards a bacterial or inflammatory infectious cause, while an increase in eosinophils suggests an allergic or parasitic reaction.
The distinction between granulocytosis and agranulocytosis is fundamental. Agranulocytosis, on the other hand, corresponds to a severe drop in granulocytes, exposing the patient to a major risk of serious infections. Both situations warrant prompt management, but the mechanisms and treatments differ radically. To better understand these mechanisms, the definition of granulocytosis according to Pharmanco details the different forms and their clinical implications.
Further reading : Everything You Need to Know About Unlocking Action Logement Funds for Your Home Purchase Loan
Common causes of granulocytosis
The body increases its production of granulocytes in response to specific stimuli. The most common cause remains acute bacterial infection: pneumonia, appendicitis, pyelonephritis. The body massively mobilizes its neutrophils to contain the pathogen.
Chronic inflammatory diseases (rheumatoid arthritis, Crohn’s disease, certain autoimmune diseases) also cause prolonged stimulation of the bone marrow. In these cases, granulocytosis persists as long as the inflammation remains active.
Other contexts trigger this elevation:
- Tissue necrosis, such as a myocardial infarction or extensive burns, releases inflammatory signals that call neutrophils in large numbers.
- Certain medications, particularly corticosteroids and hematopoietic growth factors, directly increase the number of circulating granulocytes.
- Hematological cancers, especially myeloproliferative syndromes and certain leukemias, lead to chaotic cell production in the bone marrow.
- Intense physiological stress (major surgery, extreme physical exertion) causes a transient granulocytosis by releasing the marginal pool of neutrophils.
Differentiating between a reactive cause (benign, secondary to an infection) and a clonal cause (related to a bone marrow disease) is the priority of the diagnosis.
Symptoms and warning signs to recognize
Granulocytosis itself does not produce specific symptoms. It is the underlying disease or condition that generates the clinical manifestations.
A persistent fever, unusual fatigue, or recurrent infections should prompt a consultation with a doctor. The discovery of granulocytosis often occurs during a blood test requested to explore these signs.
When the elevation of granulocytes accompanies unexplained weight loss, night sweats, or an enlarged spleen, the doctor will quickly direct the evaluation towards a hematological pathology. These symptom associations justify further examinations without delay.
In reactive forms, the symptoms of the causal infection dominate the picture: localized pain, redness, swelling, purulent secretions. Granulocytosis normalizes spontaneously once the infectious episode is resolved.
Diagnosis of granulocytosis: examinations and medical approach
The starting point remains the CBC with white blood cell count. This simple routine test identifies the type of elevated granulocyte and the extent of the increase.
The doctor then completes the evaluation based on the clinical context:
- An inflammatory assessment (CRP, ESR) looks for an infectious focus or systemic inflammation.
- A blood smear allows observation of cell morphology and detection of anomalies indicative of hematological disease.
- A bone marrow biopsy, which involves analyzing a sample of bone marrow, becomes necessary when results suggest a myeloproliferative syndrome or leukemia.
The clinical context always guides the interpretation of the count. A moderate granulocytosis in a febrile patient with a sore throat does not have the same significance as a major elevation in a patient without apparent infectious symptoms.
Treatments for granulocytosis based on the identified cause
There is no treatment that directly targets granulocytosis. Management focuses on the underlying cause, and normalization of granulocytes logically follows the resolution of the initial problem.
For bacterial infections, appropriate antibiotic treatment is sufficient in the majority of cases. The neutrophil count decreases within a few days as the infection recedes.
Chronic inflammatory diseases require ongoing treatment: immunosuppressants, biotherapies, long-term corticosteroids. Granulocytosis then fluctuates with the activity of the disease.
When a hematological pathology is involved, treatment falls under the hospital and specialized hematology. Chemotherapy, targeted therapies, or bone marrow transplantation may be considered depending on the exact type of disease and its stage.
If a medication is responsible for the elevation, discontinuation or substitution of the treatment usually brings the values back to normal. This decision rests with the prescribing doctor, who evaluates the benefit-risk ratio.
Regular monitoring by CBC remains the guiding principle of follow-up, regardless of the chosen treatment. Persistent granulocytosis despite treatment of the initial cause necessitates reconsideration of the diagnosis and expansion of investigations. Close follow-up with a doctor allows for adjustment of the therapeutic strategy and detection of any progression towards a more serious pathology.